However, the results found in this work are supported by other research indicating that the overexpression of SLIT2 could inhibit breast tumor growth in vivo, suggesting its potential as a tumor-suppressor gene [75,76], activating the phagocytic activity of M1-like tumor-associated macrophages against breast tumor cells [77]. Here, SLIT2 is linked to breast neoplasm.